Catalyst Wire Dossier Catalyst Wire Dossier

8-Chloroadenosine

8-chloroadenosine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 8-Chloroadenosine, covering 2023-12-05 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

See pricing